The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD Read More > November 9, 2020
Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases Read More > November 6, 2020
Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis Read More > November 4, 2020
Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis Read More > November 4, 2020
Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin Read More > November 4, 2020
Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context Read More > November 3, 2020
Effect of Ketamine on Rumination in Treatment-Resistant Depressive Patients Read More > November 1, 2020
Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies – PubMed Read More > November 1, 2020
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression Read More > October 31, 2020
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression Read More > October 29, 2020
